Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Andrea Rubbert-Roth

19PUBLICATIONS
76CO-AUTHORS
Aboriginal and Torres Strait Islander medicine and treatmentsGene expression (incl. microarray and other genome-wide approaches)Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

Sort by Publication Date:
|Jun 23, 2026
Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries.

|Nov 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives.

Romain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert

|Apr 02, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.

Daniel Blockmans, Sara K Penn, Arathi R Setty

|Jul 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

Roy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman

|Jul 20, 2024
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.

Andrea Rubbert-Roth, Koji Kato, Boulos Haraoui

|Dec 06, 2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.

Adrian Ciurea, Andrea Götschi, René Bräm

Pageof 4

Frequent Collaborators

5 joint publications

Axel Finckh

4 joint publications

Adrian Ciurea

3 joint publications

Andreas Kerschbaumer

3 joint publications

Hendrik Schulze-Koops

3 joint publications

Burkhard Möller

3 joint publications

Désirée van der Heijde

2 joint publications

Alexandre Sepriano

2 joint publications

Maya H Buch

2 joint publications

Paul Emery

2 joint publications

Janet E Pope

Frequent Collaborators

5 joint publications

Axel Finckh

4 joint publications

Adrian Ciurea

3 joint publications

Andreas Kerschbaumer

3 joint publications

Hendrik Schulze-Koops